TECHNEGAS
Jubilant Lifesciences gains as company calls off deal with CyclopharmShares of Jubilant Life Sciences surged 4 per cent in Thursday's trade after the company its wholly-owned subsidiary and Australia-based Cy...
TRACK SENSEX, NIFTY LIVE: Who moved my market todayIf you are reading this, chances are Sensex and Nifty are part of your daily life, and actions on Dalal Street can make or mar your day.
Fourteen stocks in focus in Thursday morning tradeThe Indian market is expected to open flat. Here is a list of top fourteen stocks that are likely to be in focus today.
Jubilant, Cyclopharm terminate pact for Technegas in US marketTechnegas is an imaging agent primarily used in Pulmonary Embolism (blockage of lung arteries). At present, it is sold in 55 countries incl...
Jubilant to market Technegas in US; signs pact with CyclopharmJubilant Life Sciences said its subsidiary Jubilant DraxImage Inc has signed a term sheet with Cyclopharm for licence to market Technegas i...
Load More